The role of adjuvant chemotherapy in small bowel adenocarcinomas
Kruti Vora, Ryan H Moy, Alfred I Neugut · 2026
Read The role of adjuvant chemotherapy in small bowel adenocarcinomas by Kruti Vora, Ryan H Moy, Alfred I Neugut (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591055.txt.
Description
Kruti Vora, Ryan Moy, and Alfred Neugut review add-on chemotherapy for small bowel cancer in 2026. The small bowel is the gut's largest segment, yet cancers there are oddly rare. Shielding may come from fast transit, rich immune tissue, and quick cell turnover.
Adenocarcinomas make up roughly a third of those rare cancers, and half arise in the duodenum. Duodenal cases fare worse than those lower down, for reasons still debated. Few trials exist, so care borrows the large bowel playbook. The review weighs what is known about chemotherapy after surgery for this cancer family, where evidence stays thin.
Catalog record
| CREATOR | Kruti Vora, Ryan H Moy, Alfred I Neugut |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |